Our illustrative case—featuring a tumor size of 20 mm and a preoperative Ki67 index of 30% that increased to 60% in the resection specimen—exemplifies how biomarker assessment can identify biologically aggressive PARM despite radiologically localized (cT2N0) disease. The gene discussed is MKI67; the disease is neoplasm.